Evidence map›Paper›PMID 35254721›Full record

ArticleEMBO molecular medicine2022

Early disruption of photoreceptor cell architecture and loss of vision in a humanized pig model of usher syndromes.

Sophia Grotz, Jessica Schäfer, Kirsten A Wunderlich, Zdenka Ellederova, Hannah Auch, Andrea Bähr, Petra Runa-Vochozkova, Janet Fadl, Vanessa Arnold, Taras Ardan and 30 more

Open access · goldAbstract read
In one paragraph

Article in EMBO molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identification of a recessiveVeterinary and animal science · 2026
    Article
  6. Article
  7. Article
  8. AFrontiers in cell and developmental biology · 2026
    Article
  9. Article
  10. Article
  11. Review
  12. Animal models for the evaluation of retinal stem cell therapies.Progress in retinal and eye research · 2025
    Review
  13. The Role of Visual Electrophysiology in Systemic Hereditary Syndromes.International journal of molecular sciences · 2025
    Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Pig Models in Retinal Research and Retinal Disease.Cold Spring Harbor perspectives in medicine · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

40 authors at 14 institutions in 6 countries.

Sophia Grotz *Chair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.
Jessica Schäfer *Institute of Molecular Physiology, Molecular Cell Biology, Johannes Gutenberg University (JGU), Mainz, Germany.
Kirsten A WunderlichInstitute of Molecular Physiology, Molecular Cell Biology, Johannes Gutenberg University (JGU), Mainz, Germany.
Zdenka EllederovaInstitute of Animal Physiology and Genetics, Czech Academy of Science, Libechov, Czech Republic.
Hannah AuchChair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.
Andrea BährCenter for Innovative Medical Models, LMU Munich, Munich, Germany.
Petra Runa-VochozkovaLarge Animal Models in Cardiovascular Research, Internal Medical Department I, TU Munich, Munich, Germany.ORCID 0000-0003-3691-0340
Janet FadlChair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.
Vanessa ArnoldInstitute of Molecular Physiology, Molecular Cell Biology, Johannes Gutenberg University (JGU), Mainz, Germany.
Taras ArdanInstitute of Animal Physiology and Genetics, Czech Academy of Science, Libechov, Czech Republic.
Miroslav VeithOphthalmology Clinic, University Hospital Kralovske Vinohrady, Praha, Czech Republic.ORCID 0000-0001-6254-436X
Gianluca SantamariaLarge Animal Models in Cardiovascular Research, Internal Medical Department I, TU Munich, Munich, Germany.
Georg DhomChair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.
Wolfgang HitzlBiostatistics and Data Science, Paracelsus Medical University, Salzburg, Austria.ORCID 0000-0002-7696-1479
Barbara KesslerChair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.ORCID 0000-0001-7036-238X
Christian EckardtCenter for Innovative Medical Models, LMU Munich, Munich, Germany.
Joshua KleinInstitute of Molecular Physiology, Molecular Cell Biology, Johannes Gutenberg University (JGU), Mainz, Germany.
Anna BrymovaInstitute of Animal Physiology and Genetics, Czech Academy of Science, Libechov, Czech Republic.
Joshua LinnertInstitute of Molecular Physiology, Molecular Cell Biology, Johannes Gutenberg University (JGU), Mainz, Germany.
Mayuko KuromeChair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.
Valeri ZakharchenkoChair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.
Andrea FischerVeterinary Faculty, Small Animal Clinics, LMU Munich, Munich, Germany.
Andreas BlutkeInstitute of Experimental Genetics, Helmholtz Center Munich, Neuherberg, Germany.
Anna DöringVeterinary Faculty, Small Animal Clinics, LMU Munich, Munich, Germany.
Stepanka SuchankovaInstitute of Experimental Medicine, Czech Academy of Science, Prague, Czech Republic.
Jiri PopelarInstitute of Experimental Medicine, Czech Academy of Science, Prague, Czech Republic.
Eduardo Rodríguez-BocanegraCentre for Ophthalmology, University Eye Hospital, University Hospital Tübingen, Tübingen, Germany.
Julia DlugaiczykDepartment of Otorhinolaryngology, Head and Neck Surgery, University Hospital Zurich (USZ), University of Zurich, Zurich, Switzerland.
Hans StrakaFaculty of Biology, LMU Munich, Planegg, Germany.
Helen May-SimeraInstitute of Molecular Physiology, Cilia Biology, JGU Mainz, Mainz, Germany.ORCID 0000-0002-9477-4036
Weiwei WangGrousbeck Gene Therapy Center, Mass Eye and Ear and Harvard Medical School, Boston, MA, USA.ORCID 0000-0003-3518-9328
Karl-Ludwig LaugwitzLarge Animal Models in Cardiovascular Research, Internal Medical Department I, TU Munich, Munich, Germany.
Luk H VandenbergheGrousbeck Gene Therapy Center, Mass Eye and Ear and Harvard Medical School, Boston, MA, USA.
Eckhard WolfChair of Molecular Animal Breeding and Biotechnology, LMU Munich, Munich, Germany.ORCID 0000-0002-0430-9510
Kerstin Nagel-WolfrumInstitute of Molecular Physiology, Molecular Cell Biology, Johannes Gutenberg University (JGU), Mainz, Germany.
Tobias PetersCentre for Ophthalmology, University Eye Hospital, University Hospital Tübingen, Tübingen, Germany.ORCID 0000-0002-9187-4904
Jan MotlikInstitute of Animal Physiology and Genetics, Czech Academy of Science, Libechov, Czech Republic.
M Dominik FischerOxford Eye Hospital, Oxford University NHS Foundation Trust, Oxford, UK.
Uwe Wolfrum *Institute of Molecular Physiology, Molecular Cell Biology, Johannes Gutenberg University (JGU), Mainz, Germany.ORCID 0000-0002-4756-5872
Nikolai Klymiuk *Center for Innovative Medical Models, LMU Munich, Munich, Germany.ORCID 0000-0003-3532-1659
Johannes Gutenberg University Mainz · DELMU Klinikum · DELudwig-Maximilians-Universität München · DECzech Academy of Sciences, Institute of Animal Physiology and Genetics · CZCzech Academy of Sciences, Institute of Experimental Medicine · CZMassachusetts Eye and Ear Infirmary · USSTZ eyetrial · DEHelmholtz Zentrum München · DEInstitute of Molecular Biology · DENuffield Orthopaedic Centre · GBParacelsus Medical University · ATUniversity Hospital Kralovske Vinohrady · CZUniversity of Zurich · CHUrologische Klinik München · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Usher syndrome (USH) is the most common form of monogenic deaf-blindness. Loss of vision is untreatable and there are no suitable animal models for testing therapeutic strategies of the ocular constituent of USH, so far. By introducing a human mutation into the harmonin-encoding USH1C gene in pigs, we generated the first translational animal model for USH type 1 with characteristic hearing defect, vestibular dysfunction, and visual impairment. Changes in photoreceptor architecture, quantitative motion analysis, and electroretinography were characteristics of the reduced retinal virtue in USH1C pigs. Fibroblasts from USH1C pigs or USH1C patients showed significantly elongated primary cilia, confirming USH as a true and general ciliopathy. Primary cells also proved their capacity for assessing the therapeutic potential of CRISPR/Cas-mediated gene repair or gene therapy in vitro. AAV-based delivery of harmonin into the eye of USH1C pigs indicated therapeutic efficacy in vivo.

Indexed as

Usher SyndromesAnimalsCell Cycle ProteinsCytoskeletal ProteinsHumansPhotoreceptor CellsSwineCell Cycle ProteinsCytoskeletal Proteinsgene therapyimpaired visionphotoreceptor morphologypig modelUsher syndrome

Identifiers

PMID35254721
PMCPMC8988205
OpenAlexW4220878960

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.